Document is current

Any future updates will be listed below

Higher incidence of dermatological immune-related adverse events in cancer patients treated with immune checkpoint inhibitors vs. other treatments: a TriNetX research network study

Crossref DOI link: https://doi.org/10.1007/s00403-025-04288-7

Published Online: 2025-05-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark